Levadex is designed to be differentiated from existing migraine treatments. It is a novel formulation of dihydroergotamine (see above structure, DHE), a drug used intravenously in clinical settings to effectively and safely treat migraines.
MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adultsFriday, May 27, 2011
Gout drug success for Novartis
Canakinumab (trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
We know that, Canakinumab was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS) by the US FDA on June 2009 and by the European Medicines Agency in October 2009. CAPS is a spectrum of autoinflammatory syndromes including familial cold autoinflammatory syndrome, Muckle–Wells syndrome, and neonatal-onset multisystem inflammatory disease.
Canakinumab was being developed by Novartis for the treatment of rheumatoid arthritis but this trial has been discontinued. Canakinumab is also in phase I clinical trials as a possible treatment for chronic obstructive pulmonary disease.
Gout drug success for Novartis
Labels:
ACZ885,
Canakinumab,
Gout,
Ilaris,
rheumatid arthritis
'Turkey tail' mushroom effectively suppresses prostate tumour development
We Know that, Turkey tail/Trametes versicolor — formerly known as Coriolus versicolor and Polyporus versicolor is an extremely common polypore mushroom which can be found throughout the world. Versicolor means 'of several colours' and it is true that this mushroom is found in a wide variety of different colours. T. versicolor is commonly called Turkey Tail because of its resemblance to the tail of the wild turkey. T. versicolor is recognized as a medicinal mushroom in Chinese medicine under the name yun zhi. In China and Japan T. versicolor is used as in immunoadjuvant therapy for cancer. Now Queensland University of Technology (QUT) researchers reported that, the mushroom has the medicinal benefits up to 100 per cent effective in suppressing prostate tumour development in mice during early trials......
'Turkey tail' mushroom effectively suppresses prostate tumour development
Labels:
antcancer activity,
Turkey tail mushroom
Wednesday, May 25, 2011
Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study
In continuation of my update on Linezolid and Vancomycin...
Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study
Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study
Labels:
drug resistant,
linezolid,
MRSA,
Vancomycin
Tuesday, May 24, 2011
Monday, May 23, 2011
Sunday, May 22, 2011
Saturday, May 21, 2011
Friday, May 20, 2011
Thursday, May 19, 2011
Merck receives FDA approval for Victrelis to treat chronic hepatitis C
In continuation of my update on Victrelis (Boceprevir)
Merck receives FDA approval for Victrelis to treat chronic hepatitis C
Merck receives FDA approval for Victrelis to treat chronic hepatitis C
Subscribe to:
Posts (Atom)